Xenon Pharmaceuticals Inc. Common Shares (XENE) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Xenon Pharmaceuticals Inc. Common Shares (XENE) is Neutral.

The composite score behind that read is -0.06, weighing +0.16 of bullish evidence against -0.25 bearish.

Xenon Pharmaceuticals Inc. Common Shares last closed at $36.44, +0.77% on the session.

Against the IVW growth benchmark the position is -0.03% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

Xenon Pharmaceuticals Inc. Common Shares has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Xenon Pharmaceuticals Inc. Common Shares in the 19th percentile on return on equity, where 100 is best.

Xenon Pharmaceuticals Inc. Common Shares is classified under Health Care / Biotechnology, with a market capitalisation of $3.50B.

StockMap tracks Xenon Pharmaceuticals Inc. Common Shares as the 62nd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Xenon Pharmaceuticals Inc. Common Shares ranks 183rd of 381 in the group, against a group median of -0.08.